Keyphrases
Inflammation
100%
Lung Tumorigenesis
100%
Lung Tumor
100%
PD-1/PD-L1 Immune Checkpoint
100%
Chronic Obstructive Pulmonary Disease
71%
Programmed Death-ligand 1 (PD-L1)
42%
PD-L1 Expression
42%
Immunosuppressive Microenvironment
42%
Lung Cancer
28%
Conditioned Medium
28%
Disease-associated
28%
Lipopolysaccharide
28%
Lipopolysaccharide-induced
28%
CD4+ T Lymphocytes
28%
Non-small Cell Lung Cancer Cells
28%
CD8+ T Lymphocytes
28%
Lung Tissue
14%
Tumor Cells
14%
Tumor Progression
14%
Tobacco Smoke
14%
Cancer Development
14%
Immune Cells
14%
Carcinogen
14%
Chronic Inflammation
14%
FoxP3+
14%
Tumor-associated Macrophages
14%
Significant Risk Factors
14%
Tumor Formation
14%
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
14%
Human Monocytes
14%
Tumor Development
14%
Phorbol 12-myristate 13-acetate
14%
Tumor Tissue
14%
Monocyte-derived Macrophages
14%
Cell Line Models
14%
Healthy Lung
14%
Relative Abundance
14%
THP1
14%
THP-1 Cells
14%
STAT3 Signaling
14%
Immune Checkpoint Molecules
14%
Immune Checkpoint Therapy
14%
Signaling Axis
14%
Medicine and Dentistry
Lung
100%
Programmed Death-Ligand 1
100%
Lung Tumor
100%
Immunity
100%
Carcinogenesis
100%
Chronic Obstructive Pulmonary Disease
71%
Lipopolysaccharide
57%
Neoplasm
42%
Immunosuppressive Drug
42%
Cancer Cell
28%
Lung Cancer
28%
Non Small Cell Lung Cancer
28%
T Lymphocyte
28%
Macrophage
28%
CD8 Antigen
28%
Tumor Progression
14%
Tumor Cell
14%
Immunocompetent Cell
14%
Phorbol 13 Acetate 12 Myristate
14%
Chronic Inflammation
14%
Epidermal Growth Factor Receptor
14%
THP1 Cell Line
14%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
14%
Carcinogen
14%
Cell Line
14%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Tumor
100%
Inflammation
100%
Carcinogenesis
100%
Chronic Obstructive Lung Disease
71%
NNK
71%
Lipopolysaccharide
57%
Neoplasm
57%
Immunosuppressive Agent
42%
Non Small Cell Lung Cancer
28%
Lung Cancer
28%
CD8 Antigen
28%
Carcinogen
14%
12-O-Tetradecanoylphorbol-13-Acetate
14%
Tumor Growth
14%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
14%
Chronic Inflammation
14%
Epidermal Growth Factor Receptor
14%
Biochemistry, Genetics and Molecular Biology
PD-L1
100%
Immune Checkpoints
100%
Carcinogenesis
100%
Lipopolysaccharide
80%
Cancer Cell
40%
T Cell
40%
CD4
40%
CD8
40%
Macrophage
20%
STAT1
20%
Immunocompetent Cell
20%
FOXP3
20%
STAT3
20%
Epidermal Growth Factor Receptor
20%
Tumor Progression
20%
Myristic Acid
20%
Tumor-Associated Macrophage
20%
Immunology and Microbiology
Programmed Death-Ligand 1
100%
Immunity
100%
Immunosuppressive Drug
60%
CD4
40%
Cancer Cell
40%
CD8
40%
T Cell
40%
Macrophage
20%
Cell Line
20%
Tumor-Associated Macrophage
20%
Immunocompetent Cell
20%
Tumor Cell
20%
FOXP3
20%
STAT3
20%
STAT1
20%